Clinical Care, Research, and Telehealth Services in the Era of Social Distancing to Mitigate COVID-19
Clinical Care, Research, and Telehealth Services in the Era of Social Distancing to Mitigate COVID-19
复制标题
DOI:
10.1007/s10461-020-02924-z
复制
发表时间:
2020-05-21
影响因子:
4.4
通讯作者:
Schneider, John
中科院分区:
文献类型:
--
作者:
Young, Sean D.;Schneider, John
The COVID-19 pandemic and its related policies have the potential to fundamentally change how healthcare delivery and public health interventions are deployed. Populations at high-risk for and/or living with HIV are especially impacted by COVID-19 and related policies, making it important to understand and plan for ways that COVID-19 might affect clinical care and research related to these populations. Social distancing is the cornerstone of COVID-19 prevention responses and follows long-standing and clear infection control principles. Infection control has focused on decreasing exposure to respiratory droplets, and maintenance of a 6-foot buffer as the primary mechanism of containment. Dramatic public health measures, including stay-at-home orders and closing of public spaces, have been implemented across the US to facilitate social distancing. Medical care systems, public health programs, and individual client care approaches are forced to rapidly adapt to these infection control measures, often without infrastructure or experience on how to do so. The perfect social distance is one where there is no chance of exposure or contact, as can be done using remote technologies. Researchers who have studied and promised the potential of telehealth technologies therefore have an urgency to demonstrate how these tools might be quickly adapted for use in new clinical settings. In this Note, we describe considerations for integrating technologies, such as telemedicine; social media, mobile applications (apps), and chatbots; and biosensors/wearables into clinical HIV care delivery and research, as well as case examples of current uses of these technologies in adapting to the changing clinical and research needs among populations at risk for and/living with HIV as a result of the COVID-19 pandemic.